search
Back to results

Mobile-Health Delivery of Lifestyle Interventions for Women With Breast Cancer

Primary Purpose

Breast Carcinoma

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Behavioral Intervention
Best Practice
FitBit
Nutrition Education
Physical Activity
Questionnaire Administration
Sponsored by
M.D. Anderson Cancer Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Breast Carcinoma

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Women with stage I-III BCa scheduled to undergo radiation therapy (RT) or within the first 12 months of having completed primary treatment (they do not need to have undergone RT)
  • Underwent chemotherapy and surgery
  • Able to read, write, and speak English
  • BMI of 25 or higher
  • 18 years of age or older
  • Oriented to person, place, and time
  • Participants must meet at least two of the following criteria related to their lifestyle at the time of diagnosis:

    • Consume less than 3 servings of fruit and vegetable/day
    • Engage in less than 75 minutes of moderate/vigorous intensity activity per week, defined as anything that causes small increases in breathing or heart rate for a sustained amount of time (e.g., brisk walking, bicycling)
    • Engage in a mind-body practice less than 4 times a month
  • Access to internet connection
  • Access to a tablet, laptop or computer
  • Able to come to University of Texas (UT) MD Anderson or Wake Forest for blood collection
  • Able to perform light physical activity. if any medical issues exist or arise that may limit performing physical activity, a medical release will be required

Exclusion Criteria:

  • Have not completed chemotherapy; have a recurrent BCa diagnosis; another primary cancer diagnosis within past 5 years (not including non-melanoma skin cancers)
  • Any major thought disorder (e.g., schizophrenia, dementia)
  • Any major communication barriers that would preclude being able to complete the intervention (e.g., visually or hearing impaired)
  • Poorly or uncontrolled diabetes in the opinion of the physician(s)
  • Extreme mobility issues (e.g., unable to get in and out of a chair unassisted)

Sites / Locations

  • M D Anderson Cancer CenterRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

GROUP I (CLIP)

GROUP II (usual care)

Arm Description

Patients undergo 60 minute sessions of nutrition education for 12 weeks and behavioral intervention 26 weeks. Patients receive FitBit and undergo physical activity for 30-60 minutes 5 days a week (aerobic activity) and 2 days a week (resistance training).

Patients have access to all usual care supportive services.

Outcomes

Primary Outcome Measures

Assess the feasibility of delivering a mobile, standardized, comprehensive lifestyle program in women with BCa.
The feasibility criteria will include consent rate (how many patients are consented in a period of time), adherence rate ( how many patients adhere to the program and finish it), and study retention rate ( how many patients that are consented stay with the program until the end/ low number of participants withdrawing from the study after consent).

Secondary Outcome Measures

Full Information

First Posted
September 17, 2021
Last Updated
March 23, 2023
Sponsor
M.D. Anderson Cancer Center
Collaborators
National Cancer Institute (NCI)
search

1. Study Identification

Unique Protocol Identification Number
NCT05132296
Brief Title
Mobile-Health Delivery of Lifestyle Interventions for Women With Breast Cancer
Official Title
Mobile-Health Delivery of Lifestyle Interventions for Women With Breast Cancer Multicenter Pilot Trial
Study Type
Interventional

2. Study Status

Record Verification Date
March 2023
Overall Recruitment Status
Recruiting
Study Start Date
May 21, 2021 (Actual)
Primary Completion Date
November 30, 2023 (Anticipated)
Study Completion Date
November 30, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
M.D. Anderson Cancer Center
Collaborators
National Cancer Institute (NCI)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This clinical trial aims to develop a lifestyle program to improve clinical outcomes in women with breast cancer who do not have a healthy diet, regular exercise habits, or ways to manage their stress well. The program will include support and counseling in healthy eating, physical activity, stress management and mindfulness, learning sleep hygiene techniques, and behavioral counseling in addition to social support. Developing a lifestyle program may help improve quality of life and encourage healthy lifestyle choices among patients diagnosed with breast cancer.
Detailed Description
PRIMARY OBJECTIVE: I. Assess the feasibility of delivering a mobile, standardized, comprehensive lifestyle program in women with breast cancer (BCa). SECONDARY OBJECTIVES: I. Determine whether the comprehensive lifestyle intervention program (CLIP) group has reduction in body mass index (BMI) and percent body fat and weight over time. II. Determine whether the CLIP group has improved outcomes in anthropometric measures, dietary patterns, and fitness measures and patient-reported outcomes including quality of life (QOL), fatigue, sleep disturbances, mental health, social support, and mindfulness. OUTLINE: Patients are randomized into 1 of 2 groups. GROUP I: Patients undergo 60 minute sessions of nutrition education for 12 weeks and behavioral intervention 26 weeks. Patients receive FitBit and undergo physical activity for 30-60 minutes 5 days a week (aerobic activity) and 2 days a week (resistance training). GROUP II: Patients have access to all usual care supportive services.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Breast Carcinoma

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
30 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
GROUP I (CLIP)
Arm Type
Experimental
Arm Description
Patients undergo 60 minute sessions of nutrition education for 12 weeks and behavioral intervention 26 weeks. Patients receive FitBit and undergo physical activity for 30-60 minutes 5 days a week (aerobic activity) and 2 days a week (resistance training).
Arm Title
GROUP II (usual care)
Arm Type
Active Comparator
Arm Description
Patients have access to all usual care supportive services.
Intervention Type
Behavioral
Intervention Name(s)
Behavioral Intervention
Other Intervention Name(s)
Behavior Conditioning Therapy, Behavior Modification, Behavior or Life Style Modifications, Behavior Therapy, Behavioral Interventions, Behavioral Modification, Behavioral Therapy, Behavioral Treatment, Behavioral Treatments
Intervention Description
Undergo behavioral counseling
Intervention Type
Other
Intervention Name(s)
Best Practice
Other Intervention Name(s)
standard of care, standard therapy
Intervention Description
Receive usual care supportive services
Intervention Type
Device
Intervention Name(s)
FitBit
Intervention Description
Receive FitBit
Intervention Type
Behavioral
Intervention Name(s)
Nutrition Education
Intervention Description
Receive nutrition education
Intervention Type
Other
Intervention Name(s)
Physical Activity
Intervention Description
Undergo physical activity
Intervention Type
Other
Intervention Name(s)
Questionnaire Administration
Intervention Description
Ancillary studies
Primary Outcome Measure Information:
Title
Assess the feasibility of delivering a mobile, standardized, comprehensive lifestyle program in women with BCa.
Description
The feasibility criteria will include consent rate (how many patients are consented in a period of time), adherence rate ( how many patients adhere to the program and finish it), and study retention rate ( how many patients that are consented stay with the program until the end/ low number of participants withdrawing from the study after consent).
Time Frame
up to 9 months after study baseline

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Women with stage I-III BCa scheduled to undergo radiation therapy (RT) or within the first 12 months of having completed primary treatment (they do not need to have undergone RT) Underwent chemotherapy and surgery Able to read, write, and speak English BMI of 25 or higher 18 years of age or older Oriented to person, place, and time Participants must meet at least two of the following criteria related to their lifestyle at the time of diagnosis: Consume less than 3 servings of fruit and vegetable/day Engage in less than 75 minutes of moderate/vigorous intensity activity per week, defined as anything that causes small increases in breathing or heart rate for a sustained amount of time (e.g., brisk walking, bicycling) Engage in a mind-body practice less than 4 times a month Access to internet connection Access to a tablet, laptop or computer Able to come to University of Texas (UT) MD Anderson or Wake Forest for blood collection Able to perform light physical activity. if any medical issues exist or arise that may limit performing physical activity, a medical release will be required Exclusion Criteria: Have not completed chemotherapy; have a recurrent BCa diagnosis; another primary cancer diagnosis within past 5 years (not including non-melanoma skin cancers) Any major thought disorder (e.g., schizophrenia, dementia) Any major communication barriers that would preclude being able to complete the intervention (e.g., visually or hearing impaired) Poorly or uncontrolled diabetes in the opinion of the physician(s) Extreme mobility issues (e.g., unable to get in and out of a chair unassisted)
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Lorezo Cohen, MD
Phone
(713) 745-4260
Email
lcohen@mdanderson.org
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Lorenzo Cohen, MD
Organizational Affiliation
M.D. Anderson Cancer Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
M D Anderson Cancer Center
City
Houston
State/Province
Texas
ZIP/Postal Code
77030
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Lorenzo Cohen, MD
Phone
713-745-2668
Email
lcohen@mdanderson.org
First Name & Middle Initial & Last Name & Degree
Lorenzo Cohen, MD

12. IPD Sharing Statement

Links:
URL
http://www.mdanderson.org
Description
M D Anderson Cancer Center

Learn more about this trial

Mobile-Health Delivery of Lifestyle Interventions for Women With Breast Cancer

We'll reach out to this number within 24 hrs